This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Aeterna Zentaris Gmbh, Centre National De La Recherche Scientifique, University of Montpellier I. Active years: 2013-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 36 
1 out of 5,383 
1 out of 4 Years Active: 2013-2014
Title: The Inventive Mind of Gilbert Mueller - Unleashing Breakthrough Pyridopyrazine Compounds
Introduction:
Gilbert Mueller, a brilliant inventor based in Frankfurt am Main, Germany, has left an indelible mark in the field of pharmaceuticals with his innovative work in developing cutting-edge pyridopyrazine compounds. With a total of 4 patents to his name, Mueller's contributions have significantly advanced the treatment and prevention of various physiological and pathophysiological states in mammals, particularly in humans.
Latest Patents:
Mueller's latest patents include groundbreaking discoveries such as "Pyridopyrazine derivatives and their use," which introduces new compounds suitable for treating conditions mediated by signal transduction pathways. Additionally, his patent on "Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors" showcases his expertise in developing compounds with immense therapeutic potential.
Career Highlights:
Throughout his career, Mueller has made notable contributions while working with esteemed organizations such as Aeterna Zentaris GmbH and the Centre National De La Recherche Scientifique. His innovative approach to drug discovery and development has led to significant advancements in the pharmaceutical industry, solidifying his reputation as a pioneer in the field.
Collaborations:
Mueller has had the privilege of collaborating with talented individuals in his field, including coworkers like Matthias Gerlach and Irene Seipelt. Together, they have synergized their expertise to drive forward groundbreaking research projects and bring novel pharmaceutical solutions to the market.
Conclusion:
In conclusion, Gilbert Mueller stands as a testament to the power of innovation and persistence in the realm of pharmaceutical inventions. His pioneering work in developing novel pyridopyrazine compounds has not only expanded our understanding of signal transduction pathways but has also opened new possibilities for the treatment of various medical conditions. Mueller's legacy as an inventive mind continues to inspire future generations of inventors and researchers in their quest for scientific excellence.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile